Anzeige
Mehr »
Login
Sonntag, 28.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Fokus auf Nurexone: High-Level Biotech im Pennystock-Kleid!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
27 Leser
Artikel bewerten:
(0)

Global and Chinese Hemodialysis Concentrates Industry Report 2014

DUBLIN, October 24, 2014 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/bfqljk/global_and) has announced the addition of the "Global and Chinese Hemodialysis Concentrates Industry Report 2014" report to their offering.

(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

Global and Chinese Hemodialysis Concentrates Industry Report 2014 is a professional and in-depth study on the current state of the hemodialysis concentrates industry with a focus on the Chinese situation.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The hemodialysis concentrates market analysis is provided for both the international and Chinese domestic situations including development trends, competitive landscape analysis, key regions development status and a comparison analysis between the international and Chinese markets.

Development policies and plans are also discussed and manufacturing processes and cost structures analyzed. Hemodialysis concentrates industry import/export consumption, supply and demand figures and cost price and production value gross margins are also provided.

The report focuses on twenty industry players providing information such as company profiles, product picture and specification, capacity production, price, cost, production value and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The hemodialysis concentrates industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 172 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Key Topics Covered:

Chapter One Hemodialysis Concentrates Industry Overview

Chapter Two Hemodialysis Concentrates International and China Market Analysis

Chapter Three Hemodialysis Concentrates Development Environmental Analysis

Chapter Four Hemodialysis Concentrates Development Policy and Plan

Chapter Five Hemodialysis Concentrates Manufacturing Process and Cost Structure

Chapter Six 2009-2014 Hemodialysis Concentrates Productions Supply Sales Demand Market Status and Forecast

Chapter Seven Hemodialysis Concentrates Key Manufacturers Analysis

Chapter Eight Up and Down Stream Industry Analysis

Chapter Nine Hemodialysis Concentrates Marketing Channels Analysis

Chapter Ten 2014-2019 Hemodialysis Concentrates Productions Supply Sales Demand Market Status and Forecast

Chapter Eleven Hemodialysis Concentrates Industry Development Proposals

Chapter Twelve Hemodialysis Concentrates New Project Investment Feasibility Analysis

Chapter Thirteen Global and China Hemodialysis Concentrates Industry Research Conclusions

Companies Mentioned:

  • B. Braun
  • Baxter (Gambro)
  • Dialysis Medical
  • Evertrust
  • Fresenius Medical Care
  • Hengxin
  • MEDIVATORS
  • Nikkiso
  • Nipro
  • Renacon Pharma
  • Rockwell Medical
  • Sanxin
  • Shenyouda
  • Sichuang
  • Surni Group
  • Taishikang
  • Unipharm JSC
  • United Jieran
  • Weigao Group
  • Ziweishan

For more information visit http://www.researchandmarkets.com/research/bfqljk/global_and

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net


Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2014 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.